Holen Sie sich die Stockscreener-App
94.16
0.26%
-0.25
Handel nachbörslich:
94.16
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$94.41
Offen:
$94
24-Stunden-Volumen:
5.68M
Relative Volume:
0.85
Marktkapitalisierung:
$75.90B
Einnahmen:
$20.38B
Nettoeinkommen (Verlust:
$2.26B
KGV:
35.92
EPS:
2.6214
Netto-Cashflow:
$3.63B
1W Leistung:
+2.47%
1M Leistung:
+15.56%
6M Leistung:
+11.18%
1J Leistung:
+8.53%
1-Tages-Spanne:
$93.37
$94.45
1-Wochen-Bereich:
$90.98
$95.65
52-Wochen-Spanne:
$74.55
$100.18
Colgate Palmolive Co Stock (CL) Company Profile
Firmenname
Colgate Palmolive Co
Sektor
Telefon
(212) 310-2000
Adresse
300 PARK AVE, NEW YORK, NY
Compare CL vs PG, UL, EL, KVUE
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CL
Colgate Palmolive Co
|
94.16 | 76.10B | 20.38B | 2.26B | 3.63B | 2.6214 |
|
PG
Procter Gamble Co
|
157.33 | 369.91B | 85.26B | 16.53B | 14.85B | 6.7488 |
|
UL
Unilever Plc Adr
|
71.36 | 157.57B | 64.99B | 6.71B | 6.53B | 2.74 |
|
EL
Estee Lauder Cos Inc
|
99.01 | 35.98B | 14.67B | -178.00M | 1.14B | -0.5002 |
|
KVUE
Kenvue Inc
|
18.18 | 34.74B | 15.01B | 1.43B | 1.63B | 0.744 |
Colgate Palmolive Co Stock (CL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-13 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2026-01-07 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2025-12-11 | Herabstufung | Argus | Buy → Hold |
| 2025-12-09 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2025-10-03 | Fortgesetzt | Piper Sandler | Neutral |
| 2024-10-28 | Herabstufung | Stifel | Buy → Hold |
| 2024-09-24 | Eingeleitet | Piper Sandler | Overweight |
| 2024-09-16 | Herabstufung | Wells Fargo | Equal Weight → Underweight |
| 2024-09-09 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2024-07-26 | Herabstufung | HSBC Securities | Buy → Hold |
| 2024-07-24 | Herabstufung | Jefferies | Buy → Hold |
| 2024-07-23 | Eingeleitet | TD Cowen | Buy |
| 2024-06-24 | Eingeleitet | Exane BNP Paribas | Outperform |
| 2024-03-01 | Fortgesetzt | Goldman | Buy |
| 2024-01-29 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2023-12-15 | Hochstufung | BofA Securities | Neutral → Buy |
| 2023-11-13 | Eingeleitet | Jefferies | Buy |
| 2023-10-16 | Hochstufung | Stifel | Hold → Buy |
| 2023-09-22 | Eingeleitet | HSBC Securities | Buy |
| 2023-02-17 | Eingeleitet | Citigroup | Buy |
| 2023-01-30 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2022-11-22 | Eingeleitet | Wolfe Research | Peer Perform |
| 2022-10-13 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2022-08-01 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2022-05-03 | Herabstufung | Atlantic Equities | Overweight → Neutral |
| 2022-04-08 | Eingeleitet | Raymond James | Mkt Perform |
| 2022-02-02 | Hochstufung | Bernstein | Underperform → Mkt Perform |
| 2022-01-31 | Bestätigt | Citigroup | Neutral |
| 2022-01-31 | Bestätigt | Credit Suisse | Outperform |
| 2022-01-31 | Bestätigt | Deutsche Bank | Buy |
| 2022-01-31 | Bestätigt | Morgan Stanley | Equal-Weight |
| 2022-01-31 | Bestätigt | Wells Fargo | Underweight |
| 2021-12-16 | Eingeleitet | Redburn | Neutral |
| 2021-10-05 | Fortgesetzt | BofA Securities | Neutral |
| 2021-09-20 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2021-06-24 | Eingeleitet | UBS | Buy |
| 2021-06-09 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2021-02-01 | Hochstufung | Credit Suisse | Underperform → Neutral |
| 2021-01-28 | Herabstufung | Stifel | Buy → Hold |
| 2021-01-26 | Hochstufung | Berenberg | Sell → Hold |
| 2021-01-20 | Eingeleitet | Bernstein | Underperform |
| 2021-01-04 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2020-12-08 | Eingeleitet | Wells Fargo | Underweight |
| 2020-07-22 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2020-03-27 | Hochstufung | Stifel | Hold → Buy |
| 2020-03-27 | Hochstufung | SunTrust | Hold → Buy |
| 2020-03-23 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2020-03-20 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2020-02-03 | Hochstufung | Atlantic Equities | Neutral → Overweight |
| 2020-02-03 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2019-12-19 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2019-10-16 | Eingeleitet | Berenberg | Sell |
| 2019-04-29 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2019-03-07 | Eingeleitet | Credit Suisse | Underperform |
| 2019-02-11 | Hochstufung | Exane BNP Paribas | Underperform → Neutral |
| 2019-01-11 | Eingeleitet | Evercore ISI | Outperform |
| 2019-01-09 | Hochstufung | Goldman | Neutral → Buy |
| 2018-10-29 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2018-10-26 | Herabstufung | SunTrust | Buy → Hold |
| 2018-07-30 | Herabstufung | Macquarie | Outperform → Neutral |
| 2018-05-25 | Hochstufung | Argus | Hold → Buy |
| 2018-04-30 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
Alle ansehen
Colgate Palmolive Co Aktie (CL) Neueste Nachrichten
United States Household Cleaning Products Market Size, Share, - openPR.com
Colgate (CL) Is Consistent, Says Jim Cramer - Finviz
Have Insiders Sold Colgate-Palmolive Shares Recently? - simplywall.st
Colgate-Palmolive CEO Wallace sells $4.27 million in stock By Investing.com - Investing.com Nigeria
Colgate-Palmolive CEO Wallace sells $4.27 million in stock - Investing.com
Colgate-Palmolive Co (CL) Stock Price, Trades & News - GuruFocus
Stanley Sutula III Sells 97,843 Shares of Colgate-Palmolive (NYSE:CL) Stock - MarketBeat
Colgate-Palmolive’s 2030 Reset—Can Execution Deliver Durable Growth and Margin Resilience? - Smartkarma
Colgate-Palmolive (CL) CEO Sells Over 45,000 Shares - GuruFocus
Colgate Palmolive (NYSE:CL) Rally Hints At Stronger Performance In S&P 500 - Kalkine Media
4 Resilient Sectors and Stocks to Watch If the Tech Selloff Returns - Investing.com
ABN AMRO Bank N.V. Sells 31,430 Shares of Colgate-Palmolive Company $CL - MarketBeat
Colgate-Palmolive: A Much-Needed Shelter For Returns In 2026 (NYSE:CL) - Seeking Alpha
Barclays Lifts Colgate (CL) Target as 2026 Growth Outlook Improves - Finviz
Colgate-Palmolive Company $CL Shares Purchased by BI Asset Management Fondsmaeglerselskab A S - MarketBeat
Individual investors own 25% of Colgate-Palmolive (India) Limited (NSE:COLPAL) shares but public companies control 51% of the company - simplywall.st
GST trickle-down? MNC CEOs cheer India sales while low-income consumers lag - The Economic Times
Is Colgate-Palmolive (CL) Still Attractive After Its Recent Share Price Surge? - simplywall.st
Analysts Offer Insights on Consumer Goods Companies: Church & Dwight (CHD) and Colgate-Palmolive (CL) - The Globe and Mail
This Once-Sleepy Consumer Staples Stock Is Beating the S&P 500 by 8-to-1 in 2026: Should You Buy? - Finviz
Colgate-Palmolive’s 2025 Earnings: Solid Profits and Clear Path to Net Zero by 2040 - CarbonCredits.com
Colgate-Palmolive (CL) Receives Mixed Analyst Rating with Target Price Increase | CL Stock News - GuruFocus
Colgate-Palmolive Forecasts Upbeat Annual Sales As Essential Spending Holds Firm - checkout.ie
Colgate-Palmolive shares jump following strong 2025 results - The Grocer
A Look At Colgate-Palmolive (CL) Valuation After Q4 Earnings Beat And 2030 Growth Plan Unveiling - simplywall.st
Colgate-Palmolive (NYSE:CL) Gains Attention In Consumer Staples S&P 500 - Kalkine Media
Colgate stock pops after hours as Wall Street lifts targets — what’s next for NYSE:CL - TechStock²
Colgate-Palmolive (CL) Receives Maintained Rating with Price Target Increase | CL Stock News - GuruFocus
Jefferies Financial Group Issues Positive Forecast for Colgate-Palmolive (NYSE:CL) Stock Price - MarketBeat
Citigroup Raises Price Target for Colgate-Palmolive (CL) to $105 | CL Stock News - GuruFocus
Colgate-Palmolive (CL) Price Target Raised by JP Morgan to $97 | - GuruFocus
Colgate-Palmolive (NYSE:CL) Price Target Raised to $97.00 - MarketBeat
Colgate-Palmolive Analysts Boost Their Forecasts Following Better-Than-Expected Q4 Results - Benzinga
Colgate-Palmolive stock rating reiterated at Buy by UBS on strong Q4 - Investing.com Australia
Wells Fargo Maintains Equal-Weight on Colgate-Palmolive (CL), Ra - GuruFocus
Evercore ISI Group Raises Price Target for CL, Maintains Outperf - GuruFocus
Colgate-Palmolive (CL): Piper Sandler Raises Price Target to $96 - GuruFocus
Why Colgate-Palmolive is moving talent across borders to develop leaders - Yahoo Finance UK
Colgate-Palmolive (NYSE:CL) Price Target Raised to $100.00 at Bank of America - MarketBeat
Colgate-Palmolive (CL) Price Target Raised by Morgan Stanley | C - GuruFocus
Colgate-Palmolive (CL) Sees Analyst Rating Maintained and Price Target Raised | CL Stock News - GuruFocus
Deutsche Bank Maintains 'Hold' on CL, Raises Price Target to $90 - GuruFocus
Evercore ISI raises Colgate-Palmolive stock price target to $100 on growth momentum - Investing.com Nigeria
Morgan Stanley raises Colgate-Palmolive stock price target to $100 on strong emerging markets growth - Investing.com
Beyond The Numbers: 10 Analysts Discuss Colgate-Palmolive Stock - Benzinga
Palmetto Grain Brokerage - Palmetto Grain Brokerage
Are Wall Street Analysts Bullish on Colgate-Palmolive Stock? - Barchart.com
Colgate-Palmolive stock price target raised to $94 from $86 at Wells Fargo - Investing.com India
Colgate-Palmolive stock price target raised to $94 from $86 at Wells Fargo By Investing.com - Investing.com South Africa
Colgate-Palmolive stock price target raised to $96 from $86 at TD Cowen By Investing.com - Investing.com South Africa
Colgate-Palmolive Company (CL) PT Raised to $100 at Morgan Stanley, 'Top HPC Pick' - StreetInsider
Finanzdaten der Colgate Palmolive Co-Aktie (CL)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.46%
0.28%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):